Furthermore, experimental inhibition of CCR5, a chemokine receptor preferentially involved in Ly6Clow monocyte recruitment to atherosclerotic plaque (43), has resulted in decreased atherosclerosis formation (42, 44). Here, CCR5 is linked to atherosclerosis.